Minute Insight: Thermo Fisher Scientific Wins FDA Clearance For Preeclampsia Blood Test
Executive Summary
The FDA cleared Thermo Fisher’s in vitro diagnostic for preeclampsia, the leading cause of pregnancy morbidity and mortality, based on results from the PRAECIS study.
You may also be interested in...
Mirvie Granted Breakthrough Device Designation For Test To Identify Risk Of Preeclampsia
Mirvie’s RNA platform can identify 75% of women who develop preeclampsia months before symptoms occur.
NWW: Studies Back Nevro Pain Treatment, FTC Blesses Resonetics Nitinol Deal, Genetic Test Identifies Best RDN Patients
This week, studies supported Nevro’s spinal cord stimulation therapy and a VRx system that helps reduce pain; the American Medical Association found inconsistent insurance coverage of digital therapeutics; and Geneticure announced a cheek-swab test to identify which patients are most likely to benefit from renal denervation.
Getting Personal With Tom Miller: CEO Turned VC On Ethical Bets In Diagnostics
Medtech Insight talked to GreyBird Ventures founder Tom Miller about his investment philosophy, ethical filter in selecting diagnostics-focused start-ups, the future of diagnostics such as at-home home-testing and AI, and his life-long passion for motocross racing.